The U.S. Food and Drug Administration on Sept. 8 issued a safety alert about reports of cancers found in the capsule or scar tissue around breast implants.
The agency stated that it had received 10 reports about squamous cell carcinoma (SCC) and 12 reports about various lymphomas related to breast implants as of Sept. 1 this year. SCC is a type of skin cancer, and lymphoma is defined as cancer of the lymph nodes.
The FDA said it learned about the reports through its “continual postmarket review of breast implants” and “ongoing collaboration with external stakeholders.”
“The FDA recognizes the limitations of [medical device report] data, including that reports do not necessarily represent unique cases,” it noted….